Departments
ABOARD, short for “A personalized medicine approach for Alzheimer’s disease”, is a public-private project which aims to prepare for a future in which Alzheimer’s disease is stopped before the onset of dementia.
Why do people with MS continue to deteriorate? How can disease progression be stopped? The researchers at the MS Center Amsterdam want to find answers to these questions.
The NWA supported NewTDec* consortium takes on the challenge to inform, perform and monitor rational treatments at the patient ‘N-of-1’ level.
Genetic studies have provided important clues to which mechanisms play a role in the response to the bacteria and secondary damage to the brain.
The MS Center Amsterdam want to enable personalized treatments for people with MS. Therefore it is important to know which patient responds best to which medicine.
Endovascular stroke treatment is effective, but performed in selected hospitals. Pre-hospital identification helps paramedics to choose the right hospital.
The new research project RESET (REStoring mood after Early life Trauma) aims to alleviate depression in patients with depression and childhood trauma.
To translate diagnostic tests in Alzheimer’s disease (AD) and their related biomarkers’ values to daily practice in local memory clinics.
